UNIVERSITY HOSPITAL
- Type
- Teaching hospital
- Where
- LEXINGTON, KY
- Medicare CCN
- 180067
- Received
- $2,297,611 in 367 records, 2025 ($1,431,025 general, $866,585 research)
- Source
- CMS Open Payments search ↗
By year
| Program year | Kind | Records | Amount |
|---|---|---|---|
| 2025 | General payment | 300 | $1,431,025 |
| 2025 | Research payment | 67 | $866,585 |
By company
By nature of payment
| Nature | Records | Amount |
|---|---|---|
| Research payment | 67 | $866,585 |
| Grant | 34 | $694,681 |
| Space rental or facility fees (teaching hospital only) | 194 | $528,853 |
| Long term medical supply or device loan | 9 | $70,966 |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a v | 27 | $68,337 |
| Education | 6 | $17,000 |
| Debt forgiveness | 19 | $15,456 |
| Consulting Fee | 3 | $14,555 |
| Gift | 4 | $14,025 |
| Royalty or License | 1 | $4,149 |
| Charitable Contribution | 3 | $3,000 |
Records
| Date | Company | Amount | Nature | Form | Product | Study | Year |
|---|---|---|---|---|---|---|---|
| 2025-12-31 | Linde Gas & Equipment Inc. | $594 | Space rental or facility fees (teaching hospital only) | In-kind items and services | LGEREG081 Device, RESPIRATORY | 2025 | |
| 2025-12-31 | Scientia Vascular | $525 | Gift | In-kind items and services | Aristotle 14 Device, Neurovascular | 2025 | |
| 2025-12-31 | Takeda Pharmaceuticals U.S.A., Inc. | $46 | Research payment | Cash or cash equivalent | A Randomized, Double-blind, Placebo-Controlled Phase 3b Study to Evaluate the Short- and Long-term Efficacy and Safety | 2025 | |
| 2025-12-31 | Olympus America Inc. | $36 | Debt forgiveness | In-kind items and services | 2025 | ||
| 2025-12-31 | Novartis Pharmaceuticals Corporation | $20 | Research payment | In-kind items and services | LEQVIO Drug, Cardiology/Vascular Diseases | Randomized, Double-blind, Placebo-controlled, Multicenter Trial, Assessing the Impact of Inclisiran on Major Adverse Car | 2025 |
| 2025-12-31 | Olympus America Inc. | $17 | Debt forgiveness | In-kind items and services | Device | 2025 | |
| 2025-12-29 | Eisai Inc. | $5,000 | Space rental or facility fees (teaching hospital only) | Cash or cash equivalent | Lenvima Drug, Oncology | 2025 | |
| 2025-12-29 | BeOne Medicines USA, Inc. | $5,000 | Grant | Cash or cash equivalent | BRUKINSA Drug, Oncology | 2025 | |
| 2025-12-29 | Abbott Laboratories | $3,000 | Space rental or facility fees (teaching hospital only) | Cash or cash equivalent | NAVITOR Device, Structural Heart | 2025 | |
| 2025-12-25 | Janssen Scientific Affairs, LLC | $245,000 | Grant | Cash or cash equivalent | 2025 | ||
| 2025-12-25 | Novartis Pharmaceuticals Corporation | $1,200 | Space rental or facility fees (teaching hospital only) | Cash or cash equivalent | ILARIS Drug, Immunology | 2025 | |
| 2025-12-19 | Madrigal Pharmaceuticals | $25,135 | Research payment | Cash or cash equivalent | MASLD Pathway | 2025 | |
| 2025-12-19 | BONE SUPPORT AB | $6,995 | Research payment | Cash or cash equivalent | CERAMENTBONE VOID FILLER Device, Bone void and fracture | CERAMENT Bone Void Filler Device Registry | 2025 |
| 2025-12-17 | AstraZeneca Pharmaceuticals LP | $5,000 | Space rental or facility fees (teaching hospital only) | Cash or cash equivalent | LYNPARZA Drug, Oncology | 2025 | |
| 2025-12-17 | ARRAY BIOPHARMA INC | $5,000 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | 2025 | ||
| 2025-12-16 | Olympus America Inc. | $627 | Debt forgiveness | In-kind items and services | Olympus Device, Urology Gynecology | 2025 | |
| 2025-12-15 | AstraZeneca Pharmaceuticals LP | $5,000 | Space rental or facility fees (teaching hospital only) | Cash or cash equivalent | 2025 | ||
| 2025-12-11 | HEARTFLOW, INC. | $5,000 | Research payment | Cash or cash equivalent | FFRct Device, Coronary | 459 DECIDE Registry | 2025 |
| 2025-12-11 | HEARTFLOW, INC. | $4,000 | Research payment | Cash or cash equivalent | FFRct Device, Coronary | 459 DECIDE Registry | 2025 |
| 2025-12-11 | Genmab U.S., Inc. | $4,000 | Space rental or facility fees (teaching hospital only) | In-kind items and services | Tivdak Drug, Oncology | 2025 | |
| 2025-12-11 | Takeda Pharmaceuticals U.S.A., Inc. | $3,680 | Research payment | Cash or cash equivalent | A Randomized, Double-blind, Placebo-Controlled Phase 3b Study to Evaluate the Short- and Long-term Efficacy and Safety | 2025 | |
| 2025-12-11 | Merck Sharp & Dohme LLC | $2,000 | Space rental or facility fees (teaching hospital only) | Cash or cash equivalent | KEYTRUDA Biological, ONCOLOGY | 2025 | |
| 2025-12-05 | BioMarin Pharmaceutical Inc. | $284 | Research payment | Cash or cash equivalent | Palynziq Drug, PKU | BMN 165-306 | 2025 |
| 2025-12-04 | Regeneron Healthcare Solutions, Inc. | $9,000 | Grant | Cash or cash equivalent | DUPIXENT Biological, IMMUNOLOGY AND INFLAMMATION | 2025 | |
| 2025-12-04 | Novartis Pharmaceuticals Corporation | $200 | Space rental or facility fees (teaching hospital only) | Cash or cash equivalent | ILARIS Drug, Immunology | 2025 | |
| 2025-12-03 | DJO, LLC | $370 | Space rental or facility fees (teaching hospital only) | Cash or cash equivalent | PROCARE Device, Orthoses: Prefab (non-custom) | 2025 | |
| 2025-12-02 | Linde Gas & Equipment Inc. | $594 | Space rental or facility fees (teaching hospital only) | In-kind items and services | LGEREG081 Device, RESPIRATORY | 2025 | |
| 2025-12-01 | ABBVIE INC. | $5,000 | Space rental or facility fees (teaching hospital only) | Cash or cash equivalent | EMRELIS Drug, ONCOLOGY | 2025 | |
| 2025-11-26 | TransMedics, Inc. | $6,700 | Research payment | Cash or cash equivalent | Organ Care System Device, Device | OHP-II Registry | 2025 |
| 2025-11-25 | JAZZ PHARMACEUTICALS INC. | $2,000 | Space rental or facility fees (teaching hospital only) | Cash or cash equivalent | ZEPZELCA Drug, HEMATOLOGY/ONCOLOGY | 2025 | |
| 2025-11-25 | Linde Gas & Equipment Inc. | $330 | Space rental or facility fees (teaching hospital only) | In-kind items and services | REQNOXBOX-I Device, RESPIRATORY | 2025 | |
| 2025-11-21 | Deciphera Pharmaceuticals Inc. | $800 | Research payment | Cash or cash equivalent | ROMVIMZA Drug, ONCOLOGY | A STUDY TO EVALUATE VIMSELTINIB IN ADULTS WITH ACTIVE CHRONIC GRAFT-VERSUS-HOST DISEASE (CGVHD) | 2025 |
| 2025-11-21 | DJO, LLC | $370 | Space rental or facility fees (teaching hospital only) | Cash or cash equivalent | PROCARE Device, Orthoses: Prefab (non-custom) | 2025 | |
| 2025-11-20 | Boston Scientific Corporation | $3,000 | Grant | In-kind items and services | General - Tachy Device, General - Tachy_CRM | 2025 | |
| 2025-11-20 | Novo Nordisk Inc | $1,500 | Space rental or facility fees (teaching hospital only) | Cash or cash equivalent | 2025 | ||
| 2025-11-20 | Ipsen Biopharmaceuticals, Inc | $1,500 | Space rental or facility fees (teaching hospital only) | Cash or cash equivalent | IQIRVO Drug, Rare Disease | 2025 | |
| 2025-11-19 | ABBVIE INC. | $2,000 | Space rental or facility fees (teaching hospital only) | Cash or cash equivalent | EMRELIS Drug, ONCOLOGY | 2025 | |
| 2025-11-19 | Linde Gas & Equipment Inc. | $330 | Space rental or facility fees (teaching hospital only) | In-kind items and services | REQNOXBOX-I Device, RESPIRATORY | 2025 | |
| 2025-11-18 | HEARTFLOW, INC. | $5,000 | Research payment | Cash or cash equivalent | FFRct Device, Coronary | 459 DECIDE Registry | 2025 |
| 2025-11-18 | HEARTFLOW, INC. | $4,000 | Research payment | Cash or cash equivalent | FFRct Device, Coronary | 459 DECIDE Registry | 2025 |
| 2025-11-18 | Linde Gas & Equipment Inc. | $330 | Space rental or facility fees (teaching hospital only) | In-kind items and services | REQNOXBOX-I Device, RESPIRATORY | 2025 | |
| 2025-11-18 | Linde Gas & Equipment Inc. | $330 | Space rental or facility fees (teaching hospital only) | In-kind items and services | REQNOXBOX-I Device, RESPIRATORY | 2025 | |
| 2025-11-13 | Linde Gas & Equipment Inc. | $330 | Space rental or facility fees (teaching hospital only) | In-kind items and services | REQNOXBOX-I Device, RESPIRATORY | 2025 | |
| 2025-11-12 | Siemens Medical Solutions USA, Inc. | $5,000 | Grant | Cash or cash equivalent | 2025 | ||
| 2025-11-12 | PFIZER INC. | $4,361 | Research payment | Cash or cash equivalent | PADCEV Biological, ONCOLOGY | A STUDY OF INTRAVESICAL ENFORTUMAB VEDOTIN FOR TREATMENT OF PATIENTS WITH NONMUSCLE INVASIVE BLADDER CANCER NMIBC | 2025 |
| 2025-11-12 | ABBVIE INC. | $1,500 | Space rental or facility fees (teaching hospital only) | Cash or cash equivalent | CREON Drug, ENDOCRINOLOGY | 2025 | |
| 2025-11-12 | Novartis Pharmaceuticals Corporation | $1,200 | Space rental or facility fees (teaching hospital only) | Cash or cash equivalent | ILARIS Drug, Immunology | 2025 | |
| 2025-11-12 | Novartis Pharmaceuticals Corporation | $1,200 | Space rental or facility fees (teaching hospital only) | Cash or cash equivalent | COSENTYX Drug, Dermatology | 2025 | |
| 2025-11-11 | AstraZeneca Pharmaceuticals LP | $2,000 | Space rental or facility fees (teaching hospital only) | Cash or cash equivalent | 2025 | ||
| 2025-11-10 | Takeda Pharmaceuticals U.S.A., Inc. | $5,000 | Space rental or facility fees (teaching hospital only) | Cash or cash equivalent | FRUZAQLA Drug, ONCOLOGY | 2025 | |
| 2025-11-08 | Linde Gas & Equipment Inc. | $330 | Space rental or facility fees (teaching hospital only) | In-kind items and services | REQNOXBOX-I Device, RESPIRATORY | 2025 | |
| 2025-11-06 | Madrigal Pharmaceuticals | $25,135 | Research payment | Cash or cash equivalent | MASLD Pathway | 2025 | |
| 2025-11-05 | Janssen Biotech, Inc. | $5,000 | Space rental or facility fees (teaching hospital only) | Cash or cash equivalent | 2025 | ||
| 2025-11-05 | Alnylam Pharmaceuticals Inc. | $1,500 | Space rental or facility fees (teaching hospital only) | Cash or cash equivalent | GIVLAARI Drug, Genetic Disease | 2025 | |
| 2025-11-05 | ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | $1,500 | Grant | Cash or cash equivalent | LifeVest Device, Electromedical and Electrotherapeutic Apparatus | 2025 | |
| 2025-11-05 | Alnylam Pharmaceuticals Inc. | $1,500 | Space rental or facility fees (teaching hospital only) | Cash or cash equivalent | GIVLAARI Drug, Genetic Disease | 2025 | |
| 2025-11-04 | Genentech USA, Inc. | $5,000 | Space rental or facility fees (teaching hospital only) | Cash or cash equivalent | Tecentriq Biological, BioOncology | 2025 | |
| 2025-11-04 | Merck Sharp & Dohme LLC | $5,000 | Space rental or facility fees (teaching hospital only) | Cash or cash equivalent | WINREVAIR Biological, CARDIOVASCULAR | 2025 | |
| 2025-11-04 | Novartis Pharmaceuticals Corporation | $1,500 | Space rental or facility fees (teaching hospital only) | Cash or cash equivalent | LEQVIO Drug, Cardiology/Vascular Diseases | 2025 | |
| 2025-11-04 | Medical Device Business Services, Inc. | $1,500 | Grant | Cash or cash equivalent | 2025 | ||
| 2025-11-04 | DJO, LLC | $370 | Space rental or facility fees (teaching hospital only) | Cash or cash equivalent | PROCARE Device, Orthoses: Prefab (non-custom) | 2025 | |
| 2025-11-03 | BridgeBio Pharma, Inc. | $5,000 | Space rental or facility fees (teaching hospital only) | Cash or cash equivalent | 2025 | ||
| 2025-11-03 | Becton, Dickinson and Company | $1,500 | Space rental or facility fees (teaching hospital only) | Cash or cash equivalent | 2025 | ||
| 2025-11-03 | PFIZER INC. | $1,500 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | 2025 | ||
| 2025-11-01 | Takeda Pharmaceuticals U.S.A., Inc. | $46 | Research payment | Cash or cash equivalent | A Randomized, Double-blind, Placebo-Controlled Phase 3b Study to Evaluate the Short- and Long-term Efficacy and Safety | 2025 | |
| 2025-10-30 | ABBVIE INC. | $4,000 | Space rental or facility fees (teaching hospital only) | Cash or cash equivalent | VENCLEXTA Drug, ONCOLOGY | 2025 | |
| 2025-10-29 | H. Lundbeck A S | $8,042 | Research payment | Cash or cash equivalent | VYEPTI Biological, NEUROLOGY | A STUDY WITH EPTINEZUMAB IN CHILDREN AND ADOLESCENTS (6 TO 17 YEARS) WITH CHRONIC OR EPISODIC MIGRAINE (REJOIN) | 2025 |
| 2025-10-29 | Kite Pharma, Inc. | $4,000 | Space rental or facility fees (teaching hospital only) | Cash or cash equivalent | Yescarta Drug, CELLT | 2025 | |
| 2025-10-27 | AstraZeneca Pharmaceuticals LP | $1,200 | Space rental or facility fees (teaching hospital only) | Cash or cash equivalent | SAPHNELO Biological, Inflammation and Autoimmunity | 2025 | |
| 2025-10-27 | SANOFI US SERVICES INC. | $377 | Research payment | Cash or cash equivalent | 2025 | ||
| 2025-10-24 | AstraZeneca Pharmaceuticals LP | $4,000 | Space rental or facility fees (teaching hospital only) | Cash or cash equivalent | ENHERTU Biological, Oncology | 2025 | |
| 2025-10-24 | Takeda Pharmaceuticals U.S.A., Inc. | $2,500 | Space rental or facility fees (teaching hospital only) | Cash or cash equivalent | 2025 | ||
| 2025-10-24 | ABBVIE INC. | $1,200 | Space rental or facility fees (teaching hospital only) | Cash or cash equivalent | RINVOQ Biological, IMMUNOLOGY | 2025 | |
| 2025-10-23 | Regeneron Healthcare Solutions, Inc. | $10,000 | Grant | Cash or cash equivalent | LIBTAYO Biological, ONCOLOGY | 2025 | |
| 2025-10-23 | TransMedics, Inc. | $6,000 | Research payment | Cash or cash equivalent | Organ Care System Device, Device | OCS-LIVER-OLP-II | 2025 |
| 2025-10-23 | ABBVIE INC. | $4,500 | Space rental or facility fees (teaching hospital only) | Cash or cash equivalent | SKYRIZI Biological, IMMUNOLOGY | 2025 | |
| 2025-10-23 | Medical Device Business Services, Inc. | $3,750 | Grant | Cash or cash equivalent | 2025 | ||
| 2025-10-22 | H. Lundbeck A S | $7,918 | Research payment | Cash or cash equivalent | VYEPTI Biological, NEUROLOGY | A STUDY WITH EPTINEZUMAB IN ADOLESCENTS (12-17 YEARS) WITH CHRONIC MIGRAINE (PROSPECT-2) | 2025 |
| 2025-10-22 | Boehringer Ingelheim Pharmaceuticals, Inc. | $7,500 | Space rental or facility fees (teaching hospital only) | Cash or cash equivalent | 2025 | ||
| 2025-10-20 | ABBVIE INC. | $1,200 | Space rental or facility fees (teaching hospital only) | Cash or cash equivalent | SKYRIZI Biological, IMMUNOLOGY | 2025 | |
| 2025-10-17 | Intercept Pharmaceuticals, Inc. | $9,000 | Grant | Cash or cash equivalent | OCALIVA Drug, Hepatology / Gastroenterology | 2025 | |
| 2025-10-17 | Alexion Pharmaceuticals, Inc. | $8,000 | Gift | Cash or cash equivalent | 2025 | ||
| 2025-10-17 | SpringWorks Therapeutics, Inc. | $5,181 | Grant | Cash or cash equivalent | 2025 | ||
| 2025-10-17 | Gilead Sciences, Inc. | $4,000 | Space rental or facility fees (teaching hospital only) | Cash or cash equivalent | Trodelvy Drug, ONC | 2025 | |
| 2025-10-17 | National Marrow Donor Program | $3,960 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | 2025 | ||
| 2025-10-16 | Stryker Corporation | $4,000 | Space rental or facility fees (teaching hospital only) | Cash or cash equivalent | ALPHAVENT Device, SPORTS MEDICINE | 2025 | |
| 2025-10-16 | Sumitomo Pharma America, Inc. | $4,000 | Grant | Cash or cash equivalent | ORGOVYX Drug, PROSTATE CANCER | 2025 | |
| 2025-10-16 | Ipsen Biopharmaceuticals, Inc | $1,500 | Space rental or facility fees (teaching hospital only) | Cash or cash equivalent | Bylvay Drug, Gastroenterology | 2025 | |
| 2025-10-16 | Novo Nordisk Inc | $1,500 | Space rental or facility fees (teaching hospital only) | Cash or cash equivalent | 2025 | ||
| 2025-10-15 | PFIZER INC. | $1,500 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | 2025 | ||
| 2025-10-15 | DJO, LLC | $370 | Space rental or facility fees (teaching hospital only) | Cash or cash equivalent | PROCARE Device, Orthoses: Prefab (non-custom) | 2025 | |
| 2025-10-14 | PFIZER INC. | $1,500 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | VYNDAQEL Drug, CARDIOVASCULAR | 2025 | |
| 2025-10-14 | PFIZER INC. | $1,500 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | 2025 | ||
| 2025-10-10 | Medical Device Business Services, Inc. | $4,000 | Space rental or facility fees (teaching hospital only) | Cash or cash equivalent | 2025 | ||
| 2025-10-09 | Amgen Inc. | $10,000 | Grant | Cash or cash equivalent | IMDELLTRA (AMG757) Biological, Hematology | 2025 | |
| 2025-10-09 | ABBVIE INC. | $1,500 | Space rental or facility fees (teaching hospital only) | Cash or cash equivalent | CREON Drug, ENDOCRINOLOGY | 2025 | |
| 2025-10-09 | Linde Gas & Equipment Inc. | $330 | Space rental or facility fees (teaching hospital only) | In-kind items and services | REQNOXBOX-I Device, RESPIRATORY | 2025 | |
| 2025-10-08 | JAZZ PHARMACEUTICALS INC. | $5,000 | Space rental or facility fees (teaching hospital only) | Cash or cash equivalent | ZEPZELCA Drug, HEMATOLOGY/ONCOLOGY | 2025 | |
| 2025-10-08 | ARRAY BIOPHARMA INC | $4,000 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | 2025 | ||
| 2025-10-06 | SANOFI US SERVICES INC. | $12,000 | Research payment | Cash or cash equivalent | 2025 | ||
| 2025-10-03 | Rigel Pharmaceuticals, Inc. | $5,000 | Education | Cash or cash equivalent | TAVALISSE Drug, Hematology | 2025 | |
| 2025-10-03 | Takeda Pharmaceuticals U.S.A., Inc. | $1,287 | Research payment | Cash or cash equivalent | A Randomized, Double-blind, Placebo-Controlled Phase 3b Study to Evaluate the Short- and Long-term Efficacy and Safety | 2025 | |
| 2025-10-03 | Takeda Pharmaceuticals U.S.A., Inc. | $900 | Research payment | Cash or cash equivalent | A Randomized, Double-blind, Placebo-Controlled Phase 3b Study to Evaluate the Short- and Long-term Efficacy and Safety | 2025 | |
| 2025-10-01 | Takeda Pharmaceuticals U.S.A., Inc. | $11 | Research payment | Cash or cash equivalent | A Randomized, Double-blind, Placebo-Controlled Phase 3b Study to Evaluate the Short- and Long-term Efficacy and Safety | 2025 | |
| 2025-09-30 | Intuitive Surgical, Inc. | $15,156 | Long term medical supply or device loan | In-kind items and services | DAVINCI XI Device, SURGERY | 2025 | |
| 2025-09-30 | Intuitive Surgical, Inc. | $4,333 | Long term medical supply or device loan | In-kind items and services | DAVINCI XI Device, SURGERY | 2025 | |
| 2025-09-30 | Neurelis, Inc. | $2,500 | Education | Cash or cash equivalent | VALTOCO Drug, EPILEPSY | 2025 | |
| 2025-09-30 | Intuitive Surgical, Inc. | $2,357 | Long term medical supply or device loan | In-kind items and services | DAVINCI XI Device, SURGERY | 2025 | |
| 2025-09-30 | Olympus America Inc. | $20 | Debt forgiveness | In-kind items and services | Olympus Device, Urology Gynecology | 2025 | |
| 2025-09-29 | E.R. Squibb & Sons, L.L.C. | $4,000 | Space rental or facility fees (teaching hospital only) | Cash or cash equivalent | REBLOZYL Biological, Hematology | 2025 | |
| 2025-09-27 | Linde Gas & Equipment Inc. | $330 | Space rental or facility fees (teaching hospital only) | In-kind items and services | REQNOXBOX-I Device, RESPIRATORY | 2025 | |
| 2025-09-26 | AstraZeneca Pharmaceuticals LP | $4,000 | Space rental or facility fees (teaching hospital only) | Cash or cash equivalent | LYNPARZA Drug, Oncology | 2025 | |
| 2025-09-24 | Edwards Lifesciences Corporation | $7,500 | Space rental or facility fees (teaching hospital only) | Cash or cash equivalent | 2025 | ||
| 2025-09-24 | Novo Nordisk Inc | $1,500 | Space rental or facility fees (teaching hospital only) | Cash or cash equivalent | 2025 | ||
| 2025-09-23 | CSL Behring | $2,500 | Space rental or facility fees (teaching hospital only) | Cash or cash equivalent | 2025 | ||
| 2025-09-23 | Alnylam Pharmaceuticals Inc. | $1,500 | Space rental or facility fees (teaching hospital only) | Cash or cash equivalent | GIVLAARI Drug, Genetic Disease | 2025 | |
| 2025-09-23 | Alnylam Pharmaceuticals Inc. | $1,500 | Space rental or facility fees (teaching hospital only) | Cash or cash equivalent | GIVLAARI Drug, Genetic Disease | 2025 | |
| 2025-09-22 | PFIZER INC. | $1,500 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | VELSIPITY Drug, INFLAMMATION;PAIN | 2025 | |
| 2025-09-19 | Embecta Corp. | $1,000 | Charitable Contribution | Cash or cash equivalent | 2025 | ||
| 2025-09-19 | Embecta Corp. | $1,000 | Charitable Contribution | Cash or cash equivalent | 2025 | ||
| 2025-09-19 | Embecta Corp. | $1,000 | Charitable Contribution | Cash or cash equivalent | 2025 | ||
| 2025-09-18 | Cook Medical LLC | $15,000 | Space rental or facility fees (teaching hospital only) | Cash or cash equivalent | 2025 | ||
| 2025-09-18 | Madrigal Pharmaceuticals | $9,000 | Space rental or facility fees (teaching hospital only) | Cash or cash equivalent | REZDIFFRA Drug, LIVER DISEASE | 2025 | |
| 2025-09-18 | Ipsen Biopharmaceuticals, Inc | $1,500 | Space rental or facility fees (teaching hospital only) | Cash or cash equivalent | Bylvay Drug, Gastroenterology | 2025 | |
| 2025-09-17 | ARGENX US, INC. | $3,500 | Space rental or facility fees (teaching hospital only) | Cash or cash equivalent | VYVGART Drug, Immunology | 2025 | |
| 2025-09-16 | KYOWA KIRIN, INC. | $8,000 | Space rental or facility fees (teaching hospital only) | Cash or cash equivalent | CRYSVITA Drug, FIBROBLAST GROWTH FACTOR 23 FGF23 BLOCKING ANTIBODY | 2025 | |
| 2025-09-16 | Medical Device Business Services, Inc. | $1,130 | Grant | Cash or cash equivalent | 2025 | ||
| 2025-09-15 | ABBVIE INC. | $2,500 | Space rental or facility fees (teaching hospital only) | Cash or cash equivalent | VYALEV Drug, NEUROSCIENCE | 2025 | |
| 2025-09-12 | Ipsen Biopharmaceuticals, Inc | $8,150 | Space rental or facility fees (teaching hospital only) | Cash or cash equivalent | Onivyde Drug, Oncology | 2025 | |
| 2025-09-12 | Novartis Pharmaceuticals Corporation | $7,500 | Space rental or facility fees (teaching hospital only) | Cash or cash equivalent | LUTATHERA Drug, Oncology | 2025 | |
| 2025-09-12 | CSL Behring | $2,500 | Space rental or facility fees (teaching hospital only) | Cash or cash equivalent | 2025 | ||
| 2025-09-11 | Life Technologies Corporation | $4,149 | Royalty or License (2 payments) | Cash or cash equivalent | 2025 | ||
| 2025-09-10 | Haemonetics Corporation | $4,740 | Debt forgiveness | Cash or cash equivalent | BLOODTRACK Device, DEVICES | 2025 | |
| 2025-09-10 | Gilead Sciences, Inc. | $4,000 | Space rental or facility fees (teaching hospital only) | Cash or cash equivalent | Yeztugo Drug, HIV | 2025 | |
| 2025-09-08 | ABBVIE INC. | $1,500 | Space rental or facility fees (teaching hospital only) | Cash or cash equivalent | CREON Drug, ENDOCRINOLOGY | 2025 | |
| 2025-09-05 | DJO, LLC | $370 | Space rental or facility fees (teaching hospital only) | Cash or cash equivalent | PROCARE Device, Orthoses: Prefab (non-custom) | 2025 | |
| 2025-08-26 | Madrigal Pharmaceuticals | $50,270 | Research payment | Cash or cash equivalent | MASLD Pathway | 2025 | |
| 2025-08-22 | Novo Nordisk Inc | $81,900 | Grant | Cash or cash equivalent | 2025 | ||
| 2025-08-21 | Merck Sharp & Dohme LLC | $5,000 | Space rental or facility fees (teaching hospital only) | Cash or cash equivalent | ZERBAXA Drug, INFECTIOUS DISEASE | 2025 | |
| 2025-08-20 | JAZZ PHARMACEUTICALS INC. | $7,500 | Space rental or facility fees (teaching hospital only) | Cash or cash equivalent | ZIIHERA Drug, HEMATOLOGY/ONCOLOGY | 2025 | |
| 2025-08-19 | PFIZER INC. | $3,000 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | ELIQUIS Drug, CARDIOVASCULAR;METABOLIC DISEASE | 2025 | |
| 2025-08-19 | Gilead Sciences, Inc. | $2,000 | Space rental or facility fees (teaching hospital only) | Cash or cash equivalent | Descovy Drug, HIV | 2025 | |
| 2025-08-19 | Alnylam Pharmaceuticals Inc. | $1,500 | Space rental or facility fees (teaching hospital only) | Cash or cash equivalent | GIVLAARI Drug, Genetic Disease | 2025 | |
| 2025-08-18 | AstraZeneca Pharmaceuticals LP | $1,500 | Space rental or facility fees (teaching hospital only) | Cash or cash equivalent | WAINUA Drug, Cardiovascular and Metabolism | 2025 | |
| 2025-08-16 | Madrigal Pharmaceuticals | $2,000 | Space rental or facility fees (teaching hospital only) | Cash or cash equivalent | REZDIFFRA Drug, LIVER DISEASE | 2025 | |
| 2025-08-16 | Ipsen Biopharmaceuticals, Inc | $2,000 | Space rental or facility fees (teaching hospital only) | Cash or cash equivalent | Bylvay Drug, Gastroenterology | 2025 | |
| 2025-08-15 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | $9,000 | Space rental or facility fees (teaching hospital only) | Cash or cash equivalent | XIFAXAN Drug, Gastroenterology | 2025 | |
| 2025-08-14 | E.R. Squibb & Sons, L.L.C. | $3,750 | Space rental or facility fees (teaching hospital only) | Cash or cash equivalent | OPDIVO Biological, Oncology | 2025 | |
| 2025-08-14 | E.R. Squibb & Sons, L.L.C. | $3,750 | Space rental or facility fees (teaching hospital only) | Cash or cash equivalent | REBLOZYL Biological, Hematology | 2025 | |
| 2025-08-14 | ABBVIE INC. | $2,000 | Space rental or facility fees (teaching hospital only) | Cash or cash equivalent | SKYRIZI Biological, IMMUNOLOGY | 2025 | |
| 2025-08-12 | Melinta Therapeutics, LLC | $2,500 | Space rental or facility fees (teaching hospital only) | Cash or cash equivalent | Rezzayo Drug, ANTIFUNGALS | 2025 | |
| 2025-08-12 | Melinta Therapeutics, LLC | $2,500 | Space rental or facility fees (teaching hospital only) | Cash or cash equivalent | Rezzayo Drug, ANTIFUNGALS | 2025 | |
| 2025-08-11 | Alcresta Therapeutics, Inc. | $2,500 | Education | Cash or cash equivalent | RELIZORB Device, GASTROENTEROLOGY | 2025 | |
| 2025-08-08 | Deciphera Pharmaceuticals Inc. | $17,500 | Research payment | Cash or cash equivalent | ROMVIMZA Drug, ONCOLOGY | A STUDY TO EVALUATE VIMSELTINIB IN ADULTS WITH ACTIVE CHRONIC GRAFT-VERSUS-HOST DISEASE (CGVHD) | 2025 |
| 2025-08-08 | TransMedics, Inc. | $13,400 | Research payment | Cash or cash equivalent | Organ Care System Device, Device | OHP-II Registry | 2025 |
| 2025-08-08 | Deciphera Pharmaceuticals Inc. | $3,200 | Research payment | Cash or cash equivalent | ROMVIMZA Drug, ONCOLOGY | A STUDY TO EVALUATE VIMSELTINIB IN ADULTS WITH ACTIVE CHRONIC GRAFT-VERSUS-HOST DISEASE (CGVHD) | 2025 |
| 2025-08-08 | Genmab U.S., Inc. | $2,500 | Space rental or facility fees (teaching hospital only) | In-kind items and services | Epkinly Drug, Oncology | 2025 | |
| 2025-08-08 | Astellas Pharma US Inc | $2,500 | Space rental or facility fees (teaching hospital only) | Cash or cash equivalent | Cresemba Drug, Infectious Diseases | 2025 | |
| 2025-08-07 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | $2,000 | Space rental or facility fees (teaching hospital only) | Cash or cash equivalent | XIFAXAN Drug, Gastroenterology | 2025 | |
| 2025-08-06 | H. Lundbeck A S | $7,348 | Research payment | Cash or cash equivalent | VYEPTI Biological, NEUROLOGY | A STUDY WITH EPTINEZUMAB IN CHILDREN AND ADOLESCENTS (6 TO 17 YEARS) WITH CHRONIC OR EPISODIC MIGRAINE (REJOIN) | 2025 |
| 2025-08-06 | Linde Gas & Equipment Inc. | $338 | Space rental or facility fees (teaching hospital only) | In-kind items and services | LGEPUMP-FLOWMTR Device, RESPIRATORY | 2025 | |
| 2025-08-05 | Medical Device Business Services, Inc. | $950 | Grant | Cash or cash equivalent | 2025 | ||
| 2025-08-05 | DJO, LLC | $370 | Space rental or facility fees (teaching hospital only) | Cash or cash equivalent | PROCARE Device, Orthoses: Prefab (non-custom) | 2025 | |
| 2025-07-31 | TransMedics, Inc. | $37,074 | Research payment | Cash or cash equivalent | Organ Care System Device, Device | OCS-LIVER-OLP-II | 2025 |
| 2025-07-31 | Gilead Sciences, Inc. | $3,000 | Space rental or facility fees (teaching hospital only) | Cash or cash equivalent | Trodelvy Drug, ONC | 2025 | |
| 2025-07-28 | PFIZER INC. | $2,000 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | VELSIPITY Drug, INFLAMMATION;PAIN | 2025 | |
| 2025-07-28 | Eli Lilly and Company | $828 | Research payment | In-kind items and services | SUNRAY-01 A GLOBAL PIVOTAL STUDY IN PARTICIPANTS WITH KRAS G12C-MUTANT LOCALLY ADVANCED OR METASTATIC NON-SMALL CELL LUN | 2025 | |
| 2025-07-24 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | $5,000 | Space rental or facility fees (teaching hospital only) | Cash or cash equivalent | XIFAXAN Drug, Gastroenterology | 2025 | |
| 2025-07-24 | ARRAY BIOPHARMA INC | $2,500 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | XALKORI Drug, ONCOLOGY | 2025 | |
| 2025-07-24 | Linde Gas & Equipment Inc. | $330 | Space rental or facility fees (teaching hospital only) | In-kind items and services | REQNOXBOX-I Device, RESPIRATORY | 2025 | |
| 2025-07-23 | National Marrow Donor Program | $6,115 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | 2025 | ||
| 2025-07-22 | BeOne Medicines USA, Inc. | $2,500 | Grant | Cash or cash equivalent | BRUKINSA Drug, Oncology | 2025 | |
| 2025-07-19 | Linde Gas & Equipment Inc. | $330 | Space rental or facility fees (teaching hospital only) | In-kind items and services | REQNOXBOX-I Device, RESPIRATORY | 2025 | |
| 2025-07-18 | Takeda Pharmaceuticals U.S.A., Inc. | $7,500 | Space rental or facility fees (teaching hospital only) | Cash or cash equivalent | FRUZAQLA Drug, ONCOLOGY | 2025 | |
| 2025-07-18 | Takeda Pharmaceuticals U.S.A., Inc. | $2,000 | Space rental or facility fees (teaching hospital only) | Cash or cash equivalent | 2025 | ||
| 2025-07-16 | Kite Pharma, Inc. | $2,500 | Space rental or facility fees (teaching hospital only) | Cash or cash equivalent | Yescarta Drug, CELLT | 2025 | |
| 2025-07-16 | TransMedics, Inc. | $2,000 | Research payment | Cash or cash equivalent | Organ Care System Device, Device | OHP-II Registry | 2025 |
| 2025-07-15 | Regeneron Healthcare Solutions, Inc. | $2,500 | Grant | Cash or cash equivalent | LIBTAYO Biological, ONCOLOGY | 2025 | |
| 2025-07-10 | Gilead Sciences, Inc. | $2,500 | Space rental or facility fees (teaching hospital only) | Cash or cash equivalent | Trodelvy Drug, ONC | 2025 | |
| 2025-07-10 | DJO, LLC | $370 | Space rental or facility fees (teaching hospital only) | Cash or cash equivalent | PROCARE Device, Orthoses: Prefab (non-custom) | 2025 | |
| 2025-07-10 | Linde Gas & Equipment Inc. | $330 | Space rental or facility fees (teaching hospital only) | In-kind items and services | REQNOXBOX-I Device, RESPIRATORY | 2025 | |
| 2025-07-09 | Takeda Pharmaceuticals U.S.A., Inc. | $9,000 | Space rental or facility fees (teaching hospital only) | Cash or cash equivalent | 2025 | ||
| 2025-07-09 | AstraZeneca Pharmaceuticals LP | $2,400 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | 2025 | ||
| 2025-07-09 | AstraZeneca Pharmaceuticals LP | $77 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | 2025 | ||
| 2025-07-07 | SANOFI US SERVICES INC. | $4,000 | Consulting Fee | Cash or cash equivalent | 2025 | ||
| 2025-07-07 | SANOFI US SERVICES INC. | $143 | Consulting Fee | Cash or cash equivalent | 2025 | ||
| 2025-07-04 | TransMedics, Inc. | $2,000 | Research payment | Cash or cash equivalent | Organ Care System Device, Device | OHP Registry | 2025 |
| 2025-07-03 | Takeda Pharmaceuticals U.S.A., Inc. | $2,500 | Space rental or facility fees (teaching hospital only) | Cash or cash equivalent | 2025 | ||
| 2025-07-02 | E.R. Squibb & Sons, L.L.C. | $2,500 | Space rental or facility fees (teaching hospital only) | Cash or cash equivalent | REBLOZYL Biological, Hematology | 2025 | |
| 2025-06-30 | Medtronic, Inc. | $25,000 | Research payment | In-kind items and services | TRANSORB Device, Hernia Repair | RECOVER | 2025 |
| 2025-06-30 | Intuitive Surgical, Inc. | $16,840 | Long term medical supply or device loan | In-kind items and services | DAVINCI XI Device, SURGERY | 2025 | |
| 2025-06-30 | Intuitive Surgical, Inc. | $5,000 | Long term medical supply or device loan | In-kind items and services | DAVINCI XI Device, SURGERY | 2025 | |
| 2025-06-30 | Intuitive Surgical, Inc. | $2,720 | Long term medical supply or device loan | In-kind items and services | DAVINCI XI Device, SURGERY | 2025 | |
| 2025-06-28 | Linde Gas & Equipment Inc. | $330 | Space rental or facility fees (teaching hospital only) | In-kind items and services | REQNOXBOX-I Device, RESPIRATORY | 2025 | |
| 2025-06-25 | W. L. Gore & Associates, Inc. | $7,500 | Grant | Cash or cash equivalent | GORE-TEX Vascular Graft Device, Devices | 2025 | |
| 2025-06-18 | Takeda Pharmaceuticals U.S.A., Inc. | $9,000 | Space rental or facility fees (teaching hospital only) | Cash or cash equivalent | EOHILIA Drug, INTERNAL MEDICINE | 2025 | |
| 2025-06-18 | Takeda Pharmaceuticals U.S.A., Inc. | $9,000 | Space rental or facility fees (teaching hospital only) | Cash or cash equivalent | 2025 | ||
| 2025-06-17 | Medtronic, Inc. | $17,000 | Research payment | In-kind items and services | TRANSORB Device, Hernia Repair | RECOVER | 2025 |
| 2025-06-10 | Medtronic, Inc. | $25,000 | Research payment | In-kind items and services | TRANSORB Device, Hernia Repair | RECOVER | 2025 |
| 2025-06-05 | DJO, LLC | $370 | Space rental or facility fees (teaching hospital only) | Cash or cash equivalent | PROCARE Device, Orthoses: Prefab (non-custom) | 2025 |
The latest 200 records of 367.
CMS Open Payments: payments and transfers of value that drug and medical device makers and group purchasing organizations report to Medicare, program years 2019 on, as published by CMS (general, research and ownership records; refreshed by CMS each June and January). Links to other records on this site are by name (and state) only.
The area Census
County outline, the place (blue), the tract (orange) and the ZIP center (dot).
In Lexington-Fayette, KY, county Fayette County, KY, state Kentucky; placed by its city name.
| Measure | Place (city or town) Lexington-Fayette, KY | County Fayette County, KY | State Kentucky |
|---|---|---|---|
| Population B01003 | 323,725 | 323,725 | 4,534,824 |
| Population, 2020 census P1 | 322,570 | 322,570 | 4,505,836 |
| Median age B01002 | 35.3 | 35.3 | 39.1 |
| Under 18 B01001 | 21.0% | 21.0% | 22.6% |
| 65 and over B01001 | 14.7% | 14.7% | 17.3% |
| Households B11001 | 139,715 | 139,715 | 1,814,469 |
| Foreign born B05002 | 11.9% | 11.9% | 4.7% |
| Median household income B19013 | $69,479 | $69,479 | $63,726 |
| Median family income B19113 | $98,855 | $98,855 | $81,505 |
| Per capita income B19301 | $43,790 | $43,790 | $35,821 |
| Poverty rate B17001 | 14.9% | 14.9% | 16.1% |
| Unemployment rate B23025 | 4.9% | 4.9% | 4.9% |
| Civilian labor force B23025 | 180,472 | 180,472 | 2,152,038 |
| Mean commute (minutes) B08013 | 20.9 | 20.9 | 24.0 |
| Bachelor's degree or higher B15003 | 48.3% | 48.3% | 27.6% |
| Housing units B25001 | 148,959 | 148,959 | 2,023,116 |
| Owner-occupied B25003 | 53.8% | 53.8% | 68.3% |
| Renters B25003 | 46.2% | 46.2% | 31.7% |
| Median home value B25077 | $293,500 | $293,500 | $205,600 |
| Median gross rent B25064 | $1,164 | $1,164 | $967 |
| White, not Hispanic B03002 | 66.7% | 66.7% | 81.5% |
| Black B03002 | 14.4% | 14.4% | 7.6% |
| Hispanic or Latino B03002 | 9.5% | 9.5% | 5.0% |
| Asian B03002 | 4.3% | 4.3% | 1.6% |
| American Indian and Alaska Native B03002 | 0.0% | 0.0% | 0.1% |
Economy now FRED unemployment 4.7% in Sep 2026 (4.5% a year earlier); per capita personal income $60,835 in 2025, up 29% in five years (+3.9% after inflation); the state; Source: FRED, Federal Reserve Bank of St. Louis.
Data: IPUMS NHGIS (ACS 2020-2024 and the 2020 census); each figure links to its table for that area at data.census.gov. Records are placed by ZIP code and city name, not street address. More: everything FURP has in Lexington-Fayette, KY.
Comments